As KLRG1 downregulation accompanied increased proliferation in the steady state in standard-of-care patients with bladder cancer (Figure 4E), we looked at how PD-1 blockade affected coregulation of KLRG1 and proliferative capacity in clonally related cells. This evidence concerns the gene KLRG1 and urinary bladder cancer.